These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 16312350

  • 21. Characterization of nonfermenters from clinical samples.
    Kharangate NV, Pinto MJ, Rodrigues S, Verenkar MP.
    J Assoc Physicians India; 2001 Mar; 49():324-6. PubMed ID: 11291970
    [Abstract] [Full Text] [Related]

  • 22. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P, Tunyapanit W.
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [Abstract] [Full Text] [Related]

  • 24. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data.
    Burgess DS, Hall RG.
    Clin Ther; 2007 Jul; 29(7):1421-7. PubMed ID: 17825693
    [Abstract] [Full Text] [Related]

  • 25. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
    Cai Y, Wang R, Liang BB, An MM.
    J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
    [No Abstract] [Full Text] [Related]

  • 26. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V.
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [Abstract] [Full Text] [Related]

  • 27. Fluoroquinolones: possible additive effects in combinations against problem bacteria.
    Arr M, Graber H, Székely E.
    J Chemother; 1989 Jul; 1(4 Suppl):141-2. PubMed ID: 16312343
    [No Abstract] [Full Text] [Related]

  • 28. Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
    Hansen GT, Zhao X, Drlica K, Blondeau JM.
    Int J Antimicrob Agents; 2006 Feb; 27(2):120-4. PubMed ID: 16426820
    [Abstract] [Full Text] [Related]

  • 29. [Release of DNA from Pseudomonas aeruginosa in vitro during spontaneous growth and treatment with ciprofloxacin].
    Peng DZ, Guymon CH, McManus AT, Xiao GX.
    Zhonghua Wai Ke Za Zhi; 2005 Feb 01; 43(3):178-81. PubMed ID: 15842899
    [Abstract] [Full Text] [Related]

  • 30. Pseudomonas aeruginosa deficient in 8-oxodeoxyguanine repair system shows a high frequency of resistance to ciprofloxacin.
    Morero NR, Argaraña CE.
    FEMS Microbiol Lett; 2009 Jan 01; 290(2):217-26. PubMed ID: 19025574
    [Abstract] [Full Text] [Related]

  • 31. In vitro characterization of Ro 23-6240.
    Stobberingh E, Houben A, Van Boven C.
    Chemioterapia; 1987 Jun 01; 6(2 Suppl):154-5. PubMed ID: 3151336
    [No Abstract] [Full Text] [Related]

  • 32. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
    Lin L, Ling BD, Li XZ.
    Int J Antimicrob Agents; 2009 Jan 01; 33(1):27-32. PubMed ID: 18790612
    [Abstract] [Full Text] [Related]

  • 33. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
    Castanheira M, Jones RN, Livermore DM.
    Diagn Microbiol Infect Dis; 2009 Apr 01; 63(4):426-33. PubMed ID: 19249180
    [Abstract] [Full Text] [Related]

  • 34. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF, El-Domany RA, Zaki S, Ashour HM.
    J Antimicrob Chemother; 2007 Nov 01; 60(5):1010-7. PubMed ID: 17906321
    [Abstract] [Full Text] [Related]

  • 35. [The drug-resistant mechanism of clinical non-fermenting bacilli producing IMP-1 metalloenzyme].
    Cheng X, Jia W, Du B, Zeng W, Kang M, Zhang Z, Xie Y, Yang W, Fan H, Tao C, Zhang L.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug 01; 24(4):876-9. PubMed ID: 17899764
    [Abstract] [Full Text] [Related]

  • 36. The physicochemical and antibacterial properties of ciprofloxacin-Mg2+ complex.
    Adepoju-Bello AA, Coker HA, Eboka CJ, Abioye AO, Ayoola GA.
    Nig Q J Hosp Med; 2008 Aug 01; 18(3):133-6. PubMed ID: 19062475
    [Abstract] [Full Text] [Related]

  • 37. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
    Chin JN, Jones RN, Sader HS, Savage PB, Rybak MJ.
    J Antimicrob Chemother; 2008 Feb 01; 61(2):365-70. PubMed ID: 18079128
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A, Mahapatra A, Padhi S, Mahapatro S, Ghosh SK.
    Indian J Pathol Microbiol; 2006 Oct 01; 49(4):634-5. PubMed ID: 17183885
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
    Huang SS, Lee SC, Lee N, See LC, Tsai MH, Shieh WB.
    J Microbiol Immunol Infect; 2007 Apr 01; 40(2):134-40. PubMed ID: 17446961
    [Abstract] [Full Text] [Related]

  • 40. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E, Konkoly-Thege M, Kuti JL, Nicolau DP.
    Int J Antimicrob Agents; 2006 Nov 01; 28(5):433-8. PubMed ID: 17046212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.